bpc 157 human trial bpc-157 clinical trials studies safety Here's a nice graphic on that you can hand bpc-157 human clinical trial safety

Research from the original patent holders of BPC-157 suggests the arginate form can boost oral bioavailability from less than 3% to greater than 90%

Cell migration: In vitro studies have observed TB-500 influencing the migration of keratinocytes, endothelial cells, and fibroblasts in wound models Integrin-linked kinase (ILK) activation: Preclinical data suggest Thymosin Beta-4 activates ILK, which may play a role in cell survival signaling in experimental cardiac models Angiogenic signaling: TB-500 has been observed to stimulate endothelial cell migration and tube formation in in vitro angiogenesis assays

Age related darkening of epidermis

TB-500 appears to function mainly through actin-binding and subsequent cellular organization